After the dot-com bubble burst, stock analysts shied away from definitive stock ratings like "buy" and "sell." But as Amy Scott reports, one high-profile investment bank has had enough of the ambiguous euphemisms that replaced them.
News yesterday that a scientific study found Vioxx raised risk of heart attacks after as little as four months of use could hurt Merck's legal strategy against many Vioxx lawsuits. Stacey Vanek-Smith explains.
The nation's dominant Spanish-speaking TV network has been on the block since February. This morning it reached an agreement with a group of private equity companies that's offered $12.3 billion. Scott Tong reports.